Hugh Rogers



The Canadian Securities Exchange
Latest Comments
image_pdfimage_print

Knox Henderson interviews Hugh Rogers on XPhyto’s saliva based rapid screening test

In a recent InvestorIntel interview Knox Henderson speaks with Hugh Rogers , CEO and Director, of XPhyto Therapeutics Corp. (CSE: […]


XPhyto Therapeutics Hugh Rogers talks about rapid-results virus testing

InvestorIntel’s Peter Clausi talks with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF) about […]


The Canadian Securities Exchange